Indefinite Delivery Contract 36E79726D0019
Award Date 5/24/26
Last Date to Order 5/23/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The contract has a ceiling value of $18,554,214.00 and a period of performance from May 24, 2021 to May 23, 2022, with four one-year option periods. The contract is for the supply of levetiracetam tablets to the VA, Department of Defense...
- Xlcare Pharmaceuticals Inc. (UEI: MEAUS5WHBJJ7) was awarded a single-award Indefinite Delivery Contract by the National Acquisition Center, a civilian federal agency, on May 10, 2026, to supply Montelukast 10mg tablets to multiple federal healthcare entities. The contract carries a ceiling value of $24.8 million and encompasses a five-year performance period consisting of a base year (May 10, 2026 through May 9, 2027) plus four one-year option periods, with an ultimate completion date of May...
- This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The $11,065,099.45 single-award contract is for the supply of Oxcarbazepine tablets in various strengths and package sizes to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The one-year base period runs from October 14, 2024 to October 13, 2025, with four...
- This indefinite delivery contract represents a single-award procurement executed on May 13, 2023, by the National Acquisition Center, a civilian federal agency, to supply Lacosamide injections to the U.S. government. The prime contractor, Xlcare Pharmaceuticals Inc. (UEI: MEAUS5WHBJJ7), is a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business certified entity. The contract carries a ceiling value of $761,850.00 and encompasses a base ordering...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned small disadvantaged business, to provide Topiramate tablets over a 1-year base period and four 1-year option periods, for a total potential contract value of $14,134,788.05. The contract will support the VA, Department of Defense, Bureau of Prisons, and Indian Health Service by providing an uninterrupted supply of Topiramate tablets in...
- This single-award Indefinite Delivery Contract was executed on January 27, 2025, by the Department of Veterans Affairs National Acquisition Center to procure Levothyroxine Sodium tablets from prime contractor XLcare Pharmaceuticals Inc., a minority-owned, economically disadvantaged woman-owned small business. The contract carries a ceiling value of $40,144,392 and encompasses a one-year base ordering period from January 27, 2025, through January 26, 2026, with four one-year option periods...
- The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Exelan Pharmaceuticals Inc. to supply pregabalin capsules. The single award contract has a potential value of $54.7 million and a period of performance from March 2, 2020 through March 1, 2021, including four one-year option periods. The contract aims to procure an uninterrupted supply of pregabalin capsules in eight dosage strengths packaged in 90 count bottles. The annual estimated...
- Jubilant Cadista Pharmaceuticals Inc. has been awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Lamotrigine Immediate Release Tablets. The contract, valued at approximately $11.9 million, was awarded on June 16, 2025, with an ordering period extending through June 15, 2026, followed by four one-year option periods that could extend the contract through June 15, 2030. The procurement is unrestricted with no...
- This single-award indefinite delivery contract was awarded by the Department of Veterans Affairs National Acquisition Center to XLcare Pharmaceuticals Inc. on November 11, 2023, with a ceiling value of $54.1 million. The contract provides gabapentin capsules in various package sizes and formulations to support the pharmaceutical supply needs of the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The original solicitation, posted as a pre-solicitation notice on June 1,...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026. The contract will supply aripiprazole tablets in various package sizes to the VA,...